COPD Exacerbation Alert System With urinE anaLysis Using the HEADSTART Device (COPE-WEL)
Protocol for COPE-WEL Observational Validation Trial COPD Exacerbation Alert System With urinE anaLysis - Clinical Validation of the Headstart® Test System for Early Detection of Exacerbations in Moderate/Severe COPD Patients
Sponsor: Mologic Ltd
Terminated
Business decision
Other COPD Exacerbation trials with similar outcome
This observational or N/A phase trial investigates COPD Exacerbation and is currently terminated or withdrawn. Mologic Ltd leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Sep 2022 — Jul 2024 [monthly]
Terminated
Status: Unknown Status → Terminated
-
Apr 2022 — Sep 2022 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Apr 2022 [monthly]
Recruiting
▶ Show 1 earlier version
-
Apr 2020 — Jan 2021 [monthly]
Recruiting
First recorded
Nov 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mologic Ltd
- University Hospitals, Leicester
For direct contact, visit the study record on ClinicalTrials.gov .